Universitätsklinikum Gießen und Marburg (UKGM)

Treatment at the end of life in patients with advanced melanoma. A multicenter DeCOG study of 1067 patients from the prospective skin cancer registry ADOReg. (2025) Forschner A, Kähler KC, Gschnell M, Langan EA, Weishaupt C, Meiss F, Thoms KM, et al. Journal article Trio Exome Sequencing in VACTERL Association (2025) Ćomić J, Tilch E, Riedhammer KM, Brugger M, Brunet T, Eyring K, Vill K, et al. Journal article Exploring CAR T-Cell Dynamics: Balancing Potent Cytotoxicity and Controlled Inflammation in CAR T-Cells Derived from Systemic Sclerosis and Myositis Patients (2025) Dingfelder J, Taubmann J, von Heydebrand F, Aigner M, Bergmann C, Knitza J, Park S, et al. Journal article Tumor budding and lymphovascular invasion as prognostic factors in p16-positive oropharyngeal squamous cell carcinomas. (2025) Stögbauer F, Wirth M, Lauterbach M, Wollenberg B, Schmidl B, Hoch CC, Ourailidis I, et al. Journal article HPDL Variant Type Correlates With Clinical Disease Onset and Severity (2025) Lee EH, Kim-Mcmanus O, Yang JH, Haas R, Zaki MS, Abdel-Salam GM, Nakamura Y, et al. Journal article Impact of the digital health application ViViRA on spinal mobility, physical function, quality of life and pain perception in spondyloarthritides patients: a randomized controlled trial (2024) Palm von Alten Blaskowitz PA, Liphardt AM, Bouzas C, Coppers B, Petit P, Vuillerme N, Bundle V, et al. Journal article Digitalization is not everything but everything is nothing without digitalization Digitalisierung ist nicht alles, aber alles ist nichts ohne Digitalisierung (2024) Kiechle M, Wallwiener S, Wagner U, Fasching P Journal article Epilepsy-surgery for fronto-basal lesions: Management, outcome, and review of literature (2024) Grote A, Delev D, Hoffmann H, Elger C, von Lehe M Journal article Spectral properties of bursts in therapeutic burst suppression predict successful treatment of refractory status epilepticus (2024) Gollwitzer S, Hopfengärtner R, Rampp S, Welte T, Madžar D, Lang J, Reindl C, et al. Journal article Corrigendum to “Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harboring METex14 skipping mutations” [Eur J Cancer 207 (2024) 114158](S0959804924008141)(10.1016/j.ejca.2024.114158) (2024) Kron A, Scheffler M, Wiesweg M, Hummel HD, Kulhavy J, Gatteloehner S, Kollmeier J, et al. Journal article, Erratum